- Supported exchanges /
- PINK /
- SNNAQ.PINK
Sienna Biopharmaceuticals Inc (SNNAQ PINK) stock market data APIs
Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs in various therapeutic areas. It develops therapies in immunology and inflammation that target select pathways in tissues, such as skin. The company's lead product candidates include SNA-120, a first-in-class inhibitor of tropomyosin receptor kinase A, which is in a Phase IIb clinical trial for the treatment of psoriasis and associated pruritus; and SNA-125, a topical dual Janus kinase 3 inhibitor that is in Phase I/II clinical trials for the treatment of atopic dermatitis, psoriasis, and pruritus. It also develops SNA-001, a topical suspension of silver particles, which is in pivotal clinical trials for the treatment of acne, as well as for the reduction of light-pigmented hair, including white, gray, blonde, light brown, and light red hair. The company was formerly known as Sienna Labs, Inc. and changed its name to Sienna Biopharmaceuticals, Inc. in February 2016. Sienna Biopharmaceuticals, Inc. was founded in 2010 and is headquartered in Westlake Village, California. On December 18, 2019, Sienna Biopharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 16, 2019.
Sienna Biopharmaceuticals Inc Financial Data Overview
| 0.0001 | |
| 0.0001 | |
| - | |
| 0.0001 | |
| 0.0001 | |
| 0.0001-0.0001 | |
| 3 091 | |
| 30 908 K | |
| 0 | |
| 0 | |
| 68.813 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Sienna Biopharmaceuticals Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -43 024 000
- Earnings Per Share -1.93
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Sienna Biopharmaceuticals Inc Earnings via APIs
- Latest Release 2022-08-31
- EPS/Forecast 0
Get Sienna Biopharmaceuticals Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
